[HMG-CoA reductase inhibitors in therapy of disorders of lipid metabolism].
Windler
E
E
Medizinische Kernklinik und Poliklinik, Universitäts-Krankenhaus Eppendorf, Hamburg.
Greten
H
H
D003327:Coronary Disease / Q000097:blood / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D012307:Risk Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008055:Lipids
HMG-CoA-Reduktasehemmer in der Therapie von Lipidstoffwechselstörungen.